Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global Compliance 

This is the environment where life sciences translation, regulatory content…

EUDAMED and the New Reality for Medical Device Companies

What increased transparency means for post-market surveillance and multilingual compliance.

CASE STUDY: Creating a Future-Ready Model for Global MedTech Leader

Discover how a global MedTech leader deployed OPAL Enable to…

From Pressure to Possibility: Key Insights from our MedTech Roundtable

Anja Schaefer, Welocalize Global Head of Commercial for Life Sciences,…

The Silent Bottleneck in Clinical Trials

How translation delays jeopardize First-Patient-In, regulatory submissions, and trial start-up…

CASE STUDY: Multilingual Training Made Simple for Life Sciences Leader

Delivering a 50-minute training video subtitled in 13 languages as…